Signal and Image Processing in Biomedical Applications using Machine Learning

A special issue of Bioengineering (ISSN 2306-5354).

Deadline for manuscript submissions: closed (1 June 2022) | Viewed by 8392

Special Issue Editors


E-Mail Website
Guest Editor
Research Centre in Digitalization and Intelligent Robotics (CEDRI), Applied Management Research Unit (UNIAG), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
Interests: speech synthesis; prosody; speech systems; modulation; prediction with neural networks; DNN; LSTM; time series forecast and biological signals analysis; namely EEG; ECG and voice
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Biomedical Engineering, Medical Image and Signal Processing Laboratory, University of West Attica, 115 21 Athens, Greece
Interests: signal and image processing in biomedical applications; machine learning

E-Mail Website
Guest Editor
School of Computing, Mathematics and Engineering, Charles Sturt University, 250 Boorooma St., Wagga Wagga, NSW 2678, Australia
Interests: physiological signal processing; image processing; machine learning; neurodegenerative diseases; virtual reality

Special Issue Information

Dear Colleagues,

The dramatic improvement in biomedical sensing technology has allowed us to acquire more and better information about the human body. The data sources encompass an enormous spectrum of areas, ranging from large phenomena, such as human gait analysis from wearable sensors or eye movement analysis for disease detection, to nano scale phenomena, such as cell identification in histological microscopy or observing bone growth using microCT imaging. Hence, signal and image processing techniques have a central role in the extraction of meaningful information from such sources. In fact, advancements in signal and image processing techniques have allowed us to obtain improvements at a faster pace than the evolution of hardware. Such improvements, in such a wide landscape of data sources, have enhanced the need for advanced and specific technologies, tailored to each situation, either to improve quality or to estimate high-level information.

In addition, in recent years, artificial intelligence has been shown to offer high-performance mechanisms to deal with these situations, offering robust data models that are able to cope with large, non-linear data spaces. Training algorithms have also become increasingly efficient, being able to keep up with the evolution of data models. Good generalization capabilities and high fidelity can be achieved, even with apparently limited or sparse data. Many of these systems outperform human capacities and their use is becoming an established standard.

However, with such a fast evolution pace, the application landscape continues to grow while many challenges are still open. For each type of signal or image source, improvements can be pursued on:

  • Data collection, compression and visualization;
  • Data exploration;
  • Feature extraction, selection, enhancement and analysis;
  • Data augmentation;
  • Model selection, tuning and explainability;
  • Transfer learning;
  • Parameter space exploration.

The possibility of improving disease detection or enhancing therapies, boosting the quality of life of many people, makes this one of the most exciting current research areas.

In this Special Issue, prospective authors are invited to submit innovative research aimed to solve challenges in application areas such as, inter alia, clinical (diagnostic, rehabilitation, monitoring) and biomedical research (histology, anatomy, physiology) and human–machine interfacing (acquisition technologies, stimulation). Some of the encompassed data sources include, but are not limited to, the following:

  • Signals: EEG, EMG, ECG, EOG, electroretinogram (ERG), evoked potentials, local field potentials, deep brain stimulation (open/closed-loop), magnetoencephalography (MEG), actigraphy, gait analysis;
  • Medical imaging: X-ray, PET, CT or micro-CT, PET-CT, MRI, SPECT;
  • Biological and molecular imaging: photoacoustic/coherence tomography (PAT/OCT), MRS, mass spectrometry, optical imaging, phase-contrast imaging, laser scanning confocal microscopy (LSCM);
  • Human–machine interaction: wearable data (gaze, dynamics, heart rate), stimulation (touch, vision), emotion, disease, altered states (drunk, sleepiness).

Each small step can represent an enormous advance in clinical outcomes.

Dr. Luis Coelho
Prof. Dr. João Paulo Ramos Teixeira
Dr. Dimitris Glotsos
Dr. Abeer Alsadoon
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • signal processing
  • image processing
  • machine learning

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

16 pages, 2117 KiB  
Article
Smart-Data-Driven System for Alzheimer Disease Detection through Electroencephalographic Signals
by Teresa Araújo, João Paulo Teixeira and Pedro Miguel Rodrigues
Bioengineering 2022, 9(4), 141; https://doi.org/10.3390/bioengineering9040141 - 28 Mar 2022
Cited by 14 | Viewed by 2797
Abstract
Background: Alzheimer’s Disease (AD) stands out as one of the main causes of dementia worldwide and it represents around 65% of all dementia cases, affecting mainly elderly people. AD is composed of three evolutionary stages: Mild Cognitive Impairment (MCI), Mild and Moderate AD [...] Read more.
Background: Alzheimer’s Disease (AD) stands out as one of the main causes of dementia worldwide and it represents around 65% of all dementia cases, affecting mainly elderly people. AD is composed of three evolutionary stages: Mild Cognitive Impairment (MCI), Mild and Moderate AD (ADM) and Advanced AD (ADA). It is crucial to create a tool for assisting AD diagnosis in its early stages with the aim of halting the disease progression. Methods: The main purpose of this study is to develop a system with the ability of differentiate each disease stage by means of Electroencephalographic Signals (EEG). Thereby, an EEG nonlinear multi-band analysis by Wavelet Packet was performed enabling to extract several features from each study group. Classic Machine Learning (ML) and Deep Learning (DL) methods have been used for data classification per EEG channel. Results: The maximum accuracies obtained were 78.9% (Healthy controls (C) vs. MCI), 81.0% (C vs. ADM), 84.2% (C vs. ADA), 88.9% (MCI vs. ADM), 93.8% (MCI vs. ADA), 77.8% (ADM vs. ADA) and 56.8% (All vs. All). Conclusions: The proposed method outperforms previous studies with the same database by 2% in binary comparison MCI vs. ADM and central and parietal brain regions revealed abnormal activity as AD progresses. Full article
Show Figures

Figure 1

13 pages, 1562 KiB  
Article
Validation of Psychophysiological Measures for Caffeine Oral Films Characterization by Machine Learning Approaches
by Patrícia Batista, Pedro Miguel Rodrigues, Miguel Ferreira, Ana Moreno, Gabriel Silva, Marco Alves, Manuela Pintado and Patrícia Oliveira-Silva
Bioengineering 2022, 9(3), 114; https://doi.org/10.3390/bioengineering9030114 - 11 Mar 2022
Cited by 1 | Viewed by 2578
Abstract
(1) Background: The oral films are a new delivery system that can carry several molecules, such as neuromodulator molecules, including caffeine. These delivery systems have been developed and characterized by pharmacokinetics assays. However, new methodologies, such as psychophysiological measures, can complement their characterization. [...] Read more.
(1) Background: The oral films are a new delivery system that can carry several molecules, such as neuromodulator molecules, including caffeine. These delivery systems have been developed and characterized by pharmacokinetics assays. However, new methodologies, such as psychophysiological measures, can complement their characterization. This study presents a new protocol with psychophysiological parameters to characterize the oral film delivery systems based on a caffeine model. (2) Methods: Thirteen volunteers (61.5% females and 38.5% males) consumed caffeine oral films and placebo oral films (in different moments and without knowing the product). Electrocardiogram (ECG), electrodermal (EDA), and respiratory frequency (RF) data were monitored for 45 min. For the data analysis, the MATLAB environment was used to develop the analysis program. The ECG, EDA, and RF signals were digitally filtered and processed, using a windowing process, for feature extraction and an energy mean value for 5 min segments. Then, the data were computed and presented to the entries of a set of Machine Learning algorithms. Finally, a data statistical analysis was carried out using SPSS. (3) Results: Compared with placebo, caffeine oral films led to a significant increase in power energy in the signal spectrum of heart rate, skin conductance, and respiratory activity. In addition, the ECG time-series power energy activity revealed a better capacity to detect caffeine activity over time than the other physiological modalities. There was no significant change for the female or male gender. (4) Conclusions: The protocol developed, and the psychophysiological methodology used to characterize the delivery system profile were efficient to characterize the drug delivery profile of the caffeine. This is a non-invasive, cheap, and easy method to apply, can be used to determine the neuromodulator drugs delivery profile, and can be implemented in the future. Full article
Show Figures

Figure 1

Review

Jump to: Research

31 pages, 2550 KiB  
Review
A Narrative Review of Speech and EEG Features for Schizophrenia Detection: Progress and Challenges
by Felipe Lage Teixeira, Miguel Rocha e Costa, José Pio Abreu, Manuel Cabral, Salviano Pinto Soares and João Paulo Teixeira
Bioengineering 2023, 10(4), 493; https://doi.org/10.3390/bioengineering10040493 - 20 Apr 2023
Cited by 3 | Viewed by 2126
Abstract
Schizophrenia is a mental illness that affects an estimated 21 million people worldwide. The literature establishes that electroencephalography (EEG) is a well-implemented means of studying and diagnosing mental disorders. However, it is known that speech and language provide unique and essential information about [...] Read more.
Schizophrenia is a mental illness that affects an estimated 21 million people worldwide. The literature establishes that electroencephalography (EEG) is a well-implemented means of studying and diagnosing mental disorders. However, it is known that speech and language provide unique and essential information about human thought. Semantic and emotional content, semantic coherence, syntactic structure, and complexity can thus be combined in a machine learning process to detect schizophrenia. Several studies show that early identification is crucial to prevent the onset of illness or mitigate possible complications. Therefore, it is necessary to identify disease-specific biomarkers for an early diagnosis support system. This work contributes to improving our knowledge about schizophrenia and the features that can identify this mental illness via speech and EEG. The emotional state is a specific characteristic of schizophrenia that can be identified with speech emotion analysis. The most used features of speech found in the literature review are fundamental frequency (F0), intensity/loudness (I), frequency formants (F1, F2, and F3), Mel-frequency cepstral coefficients (MFCC’s), the duration of pauses and sentences (SD), and the duration of silence between words. Combining at least two feature categories achieved high accuracy in the schizophrenia classification. Prosodic and spectral or temporal features achieved the highest accuracy. The work with higher accuracy used the prosodic and spectral features QEVA, SDVV, and SSDL, which were derived from the F0 and spectrogram. The emotional state can be identified with most of the features previously mentioned (F0, I, F1, F2, F3, MFCCs, and SD), linear prediction cepstral coefficients (LPCC), linear spectral features (LSF), and the pause rate. Using the event-related potentials (ERP), the most promissory features found in the literature are mismatch negativity (MMN), P2, P3, P50, N1, and N2. The EEG features with higher accuracy in schizophrenia classification subjects are the nonlinear features, such as Cx, HFD, and Lya. Full article
Show Figures

Figure 1

Back to TopTop